Robert Schoen, MD
Rheumatology · Guilford, CTNPI 1689652208
Payments from drug & device makers
Across 1,322 payments — averaging $482.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$132K
- AbbVie$113K
- Lilly USA, LLC$91K
- Janssen Scientific Affairs, LLC$78K
- Johnson & Johnson$76K
- Sanofi$37K
- plus $111K from 25 others
Across 2 payments — averaging $4500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$9K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 219 | $132,098 |
| AbbVie | 276 | $112,770 |
| Lilly USA, LLC | 145 | $90,992 |
| Janssen Scientific Affairs, LLC | 68 | $77,829 |
| Johnson & Johnson | 101 | $76,032 |
| Sanofi | 35 | $37,366 |
| UCB, Inc. | 129 | $37,007 |
| Regeneron Healthcare Solutions, Inc. | 42 | $20,667 |
| E.r. Squibb & Sons, L.L.C. | 49 | $14,717 |
| Pfizer | 63 | $14,495 |
| Genentech USA, Inc. | 36 | $10,797 |
| Bristol Myers Squibb | 32 | $10,436 |
| AstraZeneca(2 entities) | 35 | $753 |
| GSK | 17 | $331 |
| Novartis | 18 | $285 |
| Boehringer Ingelheim | 10 | $241 |
| Mallinckrodt Hospital Products Inc. | 6 | $190 |
| Fresenius Kabi USA, LLC | 4 | $106 |
| Sobi, Inc | 5 | $97 |
| Merck | 7 | $97 |
| Kiniksa Pharmaceuticals, Ltd. | 4 | $95 |
| Mallinckrodt Enterprises LLC | 4 | $72 |
| Sandoz | 2 | $66 |
| Medexus Pharma, Inc. | 4 | $64 |
| Radius Health, Inc. | 2 | $61 |
| Scilex Pharmaceuticals Inc. | 3 | $61 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $58 |
| Actelion Pharmaceuticals US, Inc. | 1 | $31 |
| Aurinia Pharma U.S., Inc. | 1 | $24 |
| Organon | 1 | $19 |
| Biocon Biologics Inc | 1 | $15 |
How this compares
$637,870 in reported general payments places this provider in the 95th percentile of 118 rheumatology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Guilford
- Fotios KoumpourasNorth Haven$1.5M
- Kenneth MillerDanbury$930K
- Monique HinchcliffNorth Haven$883K
- Stuart NovackNorwalk$507K
- Bret SohnStamford$460K
- Geoffrey GladsteinTrumbull$452K
- John MagaldiTorrington$451K
- Joseph CraftNew Haven$357K
- Richard RoseffDanbury$302K
- James SeiboldFarmington$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.